Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Appointed director
CC transcript
Asset disposition
Inv. presentation
Director departure
HOLOGIC INC (HOLX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/01/2023 10-Q Quarterly Report for the period ended July 1, 2023
07/31/2023 8-K Quarterly results
05/26/2023 SD Form SD - Specialized disclosure report:
05/09/2023 144 Form 144 - Report of proposed sale of securities:
05/05/2023 144 Form 144 - Report of proposed sale of securities:
05/02/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/02/2023 10-Q Quarterly Report for the period ended April 1, 2023
05/01/2023 8-K Quarterly results
04/19/2023 8-K Quarterly results
03/10/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "HOLOGIC, INC. AMENDED AND RESTATED 2008 EQUITY INCENTIVE PLAN",
"HOLOGIC, INC. AMENDED AND RESTATED 2012 EMPLOYEE STOCK PURCHASE PLAN"
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 11.6% stake in Hologic Inc.
02/01/2023 8-K Quarterly results
02/01/2023 10-Q Quarterly Report for the period ended December 31, 2022
01/24/2023 SC 13G/A BlackRock Inc. reports a 9.6% stake in HOLOGIC INC
01/19/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
01/19/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
01/09/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2023 – Revenue of $1,074.2 Million Exceeds Guidance – – 15.8% Organic Constant Currency Growth in Diagnostics ex-COVID – – 24.5% Organic Constant Currency Growth in Molecular Diagnostics ex-COVID – – 14.7% Organic Constant Currency Growth in Surgical –"
12/09/2022 8-K Quarterly results
11/15/2022 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
11/15/2022 10-K Annual Report for the period ended September 24, 2022
11/04/2022 8-K Quarterly results
10/31/2022 8-K Quarterly results
09/23/2022 8-K Other Events  Interactive Data
08/30/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/10/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
07/27/2022 10-Q Quarterly Report for the period ended June 25, 2022
07/27/2022 8-K Quarterly results
Docs: "Hologic Announces Financial Results for Third Quarter of Fiscal 2022 – Revenue of $1.003 Billion, GAAP Diluted EPS of $0.90, and Non-GAAP Diluted EPS of $0.95 All Significantly Ahead of Expectations – – Global Organic Molecular Diagnostics ex-COVID-19 Revenue Grows Over 20% in Constant Currency – – Company Again Increases Full-Year Revenue and EPS Guidance –"
05/27/2022 SD Form SD - Specialized disclosure report:
04/27/2022 10-Q Quarterly Report for the period ended March 26, 2022
04/27/2022 8-K Quarterly results
Docs: "Hologic Announces Financial Results for Second Quarter of Fiscal 2022 – Revenue of $1.436 Billion, GAAP Diluted EPS of $1.80, and Non-GAAP Diluted EPS of $2.07 All Significantly Ahead of Expectations – – Company Again Increases Full-Year Revenue and EPS Guidance –"
03/11/2022 8-K Quarterly results
02/22/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
02/14/2022 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 16.4% stake in HOLOGIC INC
02/10/2022 SC 13G/A VANGUARD GROUP INC reports a 10.9% stake in Hologic Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy